8-K ·Filed Mar 12, 2026
8-K context-dependent: Items 8.01
Actionable Insight • Neutral
Monitor for public press releases or exhibits (e.g., EX-99.1) that may clarify the nature of the event. Absent further information, treat as routine disclosure until proven otherwise.
Final — all horizons settled through T+60d ⚠ clustered
INDV ▲ +21.89% at T+60d
NEUTRAL call ✓ call won +21.89% · α vs SPY +11.19% · entry $30.86 → $37.62
T+1d
+0.81%
call +0.81% · α +1.41%
$31.11
settled 7mo ago
T+5d
-1.17%
call -1.17% · α -0.19%
$30.50
settled 7mo ago
T+20d
-1.04%
call -1.04% · α -3.01%
$30.54
settled 6mo ago
T+60d
+21.89%
call +21.89% · α +11.19%
$37.62
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The 8-K filing includes Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), which may indicate a non-routine corporate event such as litigation, regulatory action, or disclosure of material agreements, but no specific details can be confirmed without the full filing.
Key Facts
- Filing is an 8-K for Indivior Pharmaceuticals, Inc. (INDV) reporting under Items 8.01 and 9.01
- Item 8.01 suggests disclosure of other events, potentially including litigation, regulatory developments, or public announcements
- Item 9.01 indicates inclusion of financial statements or exhibits, possibly related to acquisitions, dispositions, or material contracts
- No document content available to confirm nature or materiality of disclosed events
Financial Impact
Not specified
Risk Factors
- Potential undisclosed material event such as adverse litigation or regulatory action
- Risk of sudden price movement if material negative information is later revealed
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
18 reports for INDV
100% Hit rate best @ T+60▲ +21.73%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | EFFECT | $34.47 $35.53 | ▲ +3.08% | ▲ +2.97% | $35.71 (+3.60%) |
Aug 28, 2026 4w ago | S-4 | $34.93 $34.32 | ▼ −1.75% | ▼ −1.60% | $35.71 (+2.23%) |
Aug 3, 2026 8w ago | 425 / 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 425 | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 425 / 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Jul 23, 2026 10w ago | Press Release | $40.51 $40.22 | ▼ −0.72% | ▼ −1.19% | $35.71 (−11.85%) |
Jun 12, 2026 16w ago | Insider Cluster | $38.40 $38.32 | ▼ −0.21% | ▲ +1.17% | $35.71 (−7.01%) |
May 15, 2026 20w ago | 8-K | $36.54 $37.81 | ▲ +3.48% | ▲ +1.86% | $35.71 (−2.27%) |
May 4, 2026 21w ago | 8-K | $38.98 $38.84 | ▼ −0.36% | ▼ −3.30% | $35.71 (−8.39%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (64h 40m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access